Search

everythinglearnresearchcommunity

for

Search:↓

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Inflammation and fibrosis are not significantly different in pattern hair loss compared to controls.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

The nutritional supplement improved hair quality and reduced hair loss.

Focal atrichia helps diagnose female pattern hair loss.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Detailed history and physical examination are crucial for diagnosing hair loss.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Wolvit® (biotin 5 mg) is effective and safe for treating hair loss and scalp conditions in women.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

A systematic approach is crucial for managing hair loss in women.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

A woman's hair changed to a dry, tangled texture that's hard to comb after treatment with spironolactone, suggesting the medication might cause such hair changes.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.